Multiomic Analysis of the Prefrontal Cortex in ALS
Author Information
Author(s): Hausmann Fabian, Caldi Gomes Lucas, Hänzelmann Sonja, Khatri Robin, Oller Sergio, Gebelin Marie, Parvaz Mojan, Tzeplaeff Laura, Pasetto Laura, Zhou Qihui, Zelina Pavol, Edbauer Dieter, Pasterkamp R Jeroen, Rehrauer Hubert, Schlapbach Ralph, Carapito Christine, Bonetto Valentina, Bonn Stefan, Lingor Paul
Primary Institution: University Medical Center Hamburg-Eppendorf
Hypothesis
What are the early molecular changes in the prefrontal cortex of patients with amyotrophic lateral sclerosis (ALS)?
Conclusion
The study provides a comprehensive multiomic dataset that reveals distinct molecular subclusters in ALS patients, highlighting sex differences and potential therapeutic targets.
Supporting Evidence
- The study identified distinct molecular subclusters within ALS patients, suggesting different underlying disease mechanisms.
- Sex differences were observed in the molecular profiles, with male patients showing more pronounced alterations.
- The MAPK pathway was highlighted as a critical therapeutic target for ALS.
- Data from ALS mouse models corroborated the findings from human analyses.
- The dataset is designed to be findable, accessible, interoperable, and reproducible (FAIR).
- Comprehensive documentation of bioinformatics methodologies was provided to facilitate reproducibility.
- Ethical approval was obtained for all human and animal studies involved in the research.
- The study emphasizes the importance of early disease mechanisms in understanding ALS pathology.
Takeaway
Researchers looked at brain samples from people with ALS to find out what changes happen early in the disease, which could help in finding new treatments.
Methodology
The study involved multiomic analysis of human postmortem prefrontal cortex tissue from 51 ALS patients and 50 control subjects, along with data from 4 ALS mouse models.
Potential Biases
Potential biases may arise from the selection of brain banks and the inherent variability in postmortem tissue.
Limitations
The study primarily focuses on postmortem samples, which may not fully capture the dynamic changes occurring during disease progression.
Participant Demographics
The human cohort included 51 patients with sporadic ALS (16 females, 35 males) and 50 control subjects (28 females, 22 males), with ages ranging from 43 to 94 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website